The American Heart Association honored presentation of Capricor Therapeutics’ HOPE-3 cardiac data for deramiocel in Duchenne muscular dystrophy. The award adds

The American Heart Association honored presentation of Capricor Therapeutics’ HOPE-3 cardiac data for deramiocel in Duchenne muscular dystrophy. The award adds scientific visibility for the investigational therapy, but no regulatory or commercial update was disclosed.